Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

biOasis Technologies Ord Shs BIOAF

Healthcare Biotechnology
Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.


GREY:BIOAF - Post by User

biOasis Technologies Ord Shs > The vote
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(192)
•••
Comment by craighenryon Jan 12, 2023 12:05am
83 Views
Post# 35217493

RE:RE:RE:RE:RE:RE:RE:RE:The vote

RE:RE:RE:RE:RE:RE:RE:RE:The vote
Boomskid wrote: Absolutely. Keep on going, Craig. You're a liar.

Let me keep on going. The daughter you speak of has a Masrer's degree in political science as it relates to health care. She now a director at one of BC's health authorities in charge of some serious facilities and health care activities. She's been working at an executive level in health care for over 20 years.

She held two jobs, raised a family and got two degrees. To my knowledge, she's never been out of work for a week since she was old enough to work.

So who else in my family are you going to try to publicly destroy just because it's who you are, Craig?

jd


You are the liar JBroke. You have 3 kids remember.

You either lied to me yrs ago, or you're lying now.

You must not remember the sob story of "just not catching a break" but "she will always be your Daughter". Blah blah blah. 

I do.

Is that why you had to sell your shares JBroke? Supporting grandkids and all.  


I get it.  I really do.


Tick tock....

<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities